Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.06. | AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial | 592 | AFX News | LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L) said that results from the ECHO Phase III trial showed the company's Calquence (acalabrutinib) in combination with bendamustine and rituximab demonstrated... ► Artikel lesen | |
16.06. | Roche: Phase III Study Of Columvi Combo Extends Survival In Relapsed Diffuse Large B-Cell Lymphoma | 750 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) announced statistically significant and clinically meaningful results from its Phase III STARGLO study of Columvi (glofitamab) in combination with... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 2.624 |
EVOTEC | 2.212 |
TUI | 1.930 |
ASML | 1.893 |
VARTA | 1.626 |
NEL | 1.517 |
BAYER | 1.336 |
SUPER MICRO COMPUTER | 1.282 |
BYD | 1.203 |
TSMC | 784 |
TESLA | 727 |
DEUTSCHE LUFTHANSA | 649 |
DEUTSCHE BANK | 602 |
COMMERZBANK | 598 |
JINKOSOLAR | 563 |
NESTLE | 551 |
AIXTRON SE | 503 |
NETFLIX | 493 |
VOLKSWAGEN | 479 |
RHEINMETALL | 470 |
RWE | 454 |
DEUTSCHE TELEKOM | 448 |
JENOPTIK | 435 |
SARTORIUS AG VZ | 431 |
BASF | 427 |